Correlation between serum squamous cell carcinoma antigen level and tumor volume in Head and Neck Cancer

This is the first study that find the relationship in Squamous cell carcinoma antigen in blood compare with gross tumor and neck node volume in head and neck cancer patient that already proved pathology was squamous cell type cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20160920002

Enrollment

Registered

2016-09-20

Start date

2016-08-24

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer Squamous cell carcinoma antigen Head and neck cancer Squamous cell carcinoma antigen

Interventions

Blood sample 5 cc for squamous cell antigen

Diagnostic

Head and neck cancer patient

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Already diagnosis of Head and Neck Cancer in Squamous cell type 2. Already have CT scan with contrast in head and neck region result in 2 week before check blood squamous cell carcinoma antigen level

Exclusion criteria

Exclusion criteria: 1.Metastatic cancer of head and neck 2.Head and neck cancer that patho diag not squamous cell type 3.Renal failure 4.Lung and Skin disease that will rising squamous cell antigen

Design outcomes

Primary

Measure	Time frame
Relationship between squamous cell carcinoma antigen and gross tumor volume none Blood level	—

Secondary

Measure	Time frame
Level in squamous cell antigen in each stage of head and neck cancer none Blood level	—

Countries

Thailand

Contacts

Public ContactTeerapol Kotamnives

Hospital

hankyent@hotmail.com0840083000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026